Novartis AG (TSX:NVS)

Market Cap	355.14B
Revenue (ttm)	75.27B
Net Income (ttm)	18.62B
Shares Out	n/a
EPS (ttm)	9.34
PE Ratio	19.07
Forward PE	14.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	732
Open	24.57
Previous Close	24.57
Day's Range	24.57 - 24.57
52-Week Range	20.11 - 25.15
Beta	n/a
RSI	59.02
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD